BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Chiltern International Ltd. and EPS INTERNATIONAL International Hold a Joint Seminar in Tokyo, Japan


3/29/2009 10:20:35 PM

LONDON and TOKYO, March 27 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) that provides clinical development and staffing services in Europe, the Americas and India and its Asian partner EPS International Co. Ltd. (EPS INTERNATIONAL), a wholly owned subsidiary of EPS Co. Ltd., a leading provider of clinical development services in the Asian region, have jointly organized a seminar in Tokyo, Japan on 24th April 2009 to coincide with the 3rd anniversary of EPS International.

"We are very pleased to be part of the anniversary celebration of our partner EPS INTERNATIONAL in Japan," said Glenn Kerkhof, CEO of Chiltern. "With global consolidation in the pharma sphere, Asia is becoming an increasingly attractive market for clinical trial services. The Chiltern/EPS INTERNATIONAL partnership has been beneficial to both partners and helped continue to focus on the joint mission to deliver expert, high quality, clinical development services around the world."

"We are pleased to hold this seminar together with Chiltern International, a quality reputable global CRO having headquarters in the UK," said Tatsuhiko Ichiki, President & CEO of EPS INTERNATIONAL. "Through this seminar, it shows our commitment and expectation in this strategic collaboration enabling EPS INTERNATIONAL to expand geographical reach and attain global standard capability to best support our clients in the global drug development programs."

Chiltern provides services to EPS INTERNATIONAL from their network of offices throughout Europe, the Americas and India. Similarly, EPS INTERNATIONAL provides clinical development services for the Asian region from their offices in Japan, China, Singapore, Korea and Taiwan.

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1400 staff across 27 countries. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Further information is available at www.chiltern.com.

About EPS International:

EPS International Co. Ltd., a wholly owned subsidiary of a public listed company, EPS Co. Ltd. in Tokyo, Japan, commenced its business operations in April 2007. EPS INTERNATIONAL aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. EPS INTERNATIONAL is fully supported by a team of high caliber, diligent and dedicated clinical professionals having many years of experiences in managing large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices.

CONTACT: Mac McElroy, +1-423-968-9533, or fax, +1-423-968-3567,
mac.mcelroy@chiltern.com; or Stuart McGuire, +44-0-1753-512-000, or fax,
+44-0-1753-511-116, stuart.mcguire@chiltern.com, both of Chiltern

Web site: http://www.chiltern.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES